Johnson & Johnson Receives FDA Authorization for Ottava Surgical Robot
Johnson & Johnson (JNJ) received De Novo authorization from the FDA for its Ottava surgical robot, allowing it to be used in soft tissue procedures across general surgery. This approval marks a significant step forward for J&J's robotic-assisted surgical offerings.
Tickers: $JNJ
Topics: medical_devices robotic_surgery